‘La paradoja es que entre más desarrollo hay, mayor incidencia de cáncer’: Instituto Nacional de Cancerología

TL;DR

Cancer incidence in Colombia is projected to increase by 25-30% by 2030, linked to an aging population and higher Human Development Index.
Cancer is the second leading cause of death in Colombia, with late diagnoses being a significant challenge.
Prostate and breast cancer are the most frequent types, followed by stomach, colon, rectal, lymphoma, and lung cancers.
Mortality rates have decreased slightly since 1997, but a high percentage of cancers are diagnosed in advanced stages.
Departments with the highest mortality rates include Valle del Cauca, Antioquia, Norte de Santander, and Bogotá.
Prevention strategies like HPV vaccination and increased taxes on tobacco and alcohol are highlighted as cost-effective measures.
Challenges remain in implementing early detection programs and ensuring timely access to diagnosis, treatment, and medication within the health system.
Law 2291 of 2023 aims to strengthen the National Cancer Institute in research, innovation, public health, and epidemiological surveillance.
There is a need for more integrated oncology services to improve patient survival and reduce healthcare costs.
High costs of advanced oncological treatments and medications pose a significant financial burden on the healthcare system.

Continuar leyendo el artículo original